We are live on ! Find out more
PBH icon

Prestige Consumer Healthcare
PBH

Fund managers haven’t disclosed any holdings of PBH yet.

PBH Hedge Fund Activity: Q1 2026 in Review

355 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q1 2026, worth a combined $3.08B — down 3.4% from $3.19B a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new PBH positions and 43 closed out — a net gain of 12 holders — while 133 added to existing stakes and 129 trimmed.

The largest buyer was Silvercrest Asset Management, opening a new position worth an estimated $31.2M. The largest seller was Nomura Asset Management International, cutting an estimated $22.8M.

  • 355 institutional investors held Prestige Consumer Healthcare (PBH) as of Q1 2026, up from 354 in Q4 2025.
  • Funds reported $3.08B of Prestige Consumer Healthcare stock for Q1 2026, down 3.4% quarter-over-quarter.
  • 55 funds opened new Prestige Consumer Healthcare positions in Q1 2026 and 43 closed out, a net change of +12 holders.
  • The largest Prestige Consumer Healthcare buyer in Q1 2026 was Silvercrest Asset Management, an estimated $31.2M added.
  • The largest Prestige Consumer Healthcare seller in Q1 2026 was Nomura Asset Management International, an estimated $22.8M sold.

Based on aggregated 13F filings for Q1 2026.